Christian Périgaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian Périgaud has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Gilles Gosselin
Laboratoire de Chimie Bioorganique, UMR CNRS‐USTL 5625, Case courrier 008, Université de Montpellier II, Sciences et Techniques du Languedoc, Place Eugène Bataillon, 34095 Montpellier Cédex 5, France
4 shared publications Gilles Gosselin
Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS - UM 1 & 2, Université Montpellier 2, Case courrier 1705, place E. Bataillon, 34095 Montpellier Cedex 5, France
3 shared publications- Jean-Louis Imbach
Laboratoire de Chimie Bioorganique, UMR CNRS‐USTL 5625, Case courrier 008, Université de Montpellier II, Sciences et Techniques du Languedoc, Place Eugène Bataillon, 34095 Montpellier Cédex 5, France
3 shared publications Anne-Marie Aubertin
Université Louis Pasteur, INSERM 544, 67000 Strasbourg, France
2 shared publications- Christophe Mathé
Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, Université de Montpellier, CNRS, ENSCM, cc 1705, Site Triolet, Place Eugène Bataillon, 34095 Montpellier cedex 5, France
2 shared publications David Egron
2 shared publications
Latest Publications
- 6 June 2011
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2011 (20-21) , 3794-3802
Synthesis of Pyrimidine‐Containing Nucleoside β‐(R/S)‐Hydroxyphosphonate Analogues
- 6 June 2011
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2011 (20-21) , 3794-3802
Synthesis of Pyrimidine‐Containing Nucleoside β‐(R/S)‐Hydroxyphosphonate Analogues
- 15 July 2008
- Published by Elsevier in International Journal of Mass Spectrometry
- Vol. 274 (1-3) , 70-74
Electrospray ionization mass spectrum of S-Acyl-2-thioethyl phosphoramidate diester derivatives
- 15 July 2008
- Published by Elsevier in International Journal of Mass Spectrometry
- Vol. 274 (1-3) , 70-74
Electrospray ionization mass spectrum of S-Acyl-2-thioethyl phosphoramidate diester derivatives
- 18 June 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (15) , 7321-7329
Phenyl phosphotriester derivatives of AZT: Variations upon the SATE moiety
- 18 June 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (15) , 7321-7329
Phenyl phosphotriester derivatives of AZT: Variations upon the SATE moiety
- 26 November 2007
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 26 (8-9) , 1125-1128
Revisited 3′-Deoxy-3′-C-Methyl-β-D-Ribonucleoside Series
The synthesis of some 3′-deoxy-3′-C-methylnucleoside analogues bearing naturally occuring nucleic acid bases was achieved from the preparation of a suitable peracylated 3-deoxy-3-C-methyl sugar using a stereoselective pathway. In addition, examples of chemical modifications at the 2′ position are presented.
- 26 November 2007
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 26 (8-9) , 1125-1128
Revisited 3′-Deoxy-3′-C-Methyl-β-D-Ribonucleoside Series
The synthesis of some 3′-deoxy-3′-C-methylnucleoside analogues bearing naturally occuring nucleic acid bases was achieved from the preparation of a suitable peracylated 3-deoxy-3-C-methyl sugar using a stereoselective pathway. In addition, examples of chemical modifications at the 2′ position are presented.
- 1 December 2001
- Published by Elsevier in Bioorganic Chemistry
- Vol. 29 (6) , 333-344
Synthesis, Anti-HIV Activity, and Stability Studies of 5′-Phosphorofluoridate Derivatives of AZT
- 1 December 2001
- Published by Elsevier in Bioorganic Chemistry
- Vol. 29 (6) , 333-344
Synthesis, Anti-HIV Activity, and Stability Studies of 5′-Phosphorofluoridate Derivatives of AZT
- 27 November 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (2) , 265-266
Increase of the adenallene anti-HIV activity in cell culture using its bis(tBuSATE) phosphotriester derivative.
- 27 November 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (2) , 265-266
Increase of the adenallene anti-HIV activity in cell culture using its bis(tBuSATE) phosphotriester derivative.
- 22 January 1999
- Published by Elsevier in Antiviral Research
- Vol. 40 (3) , 179-187
The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
- 22 January 1999
- Published by Elsevier in Antiviral Research
- Vol. 40 (3) , 179-187
The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
- 1 July 1997
- Published by Taylor & Francis in Nucleosides and Nucleotides
- Vol. 16 (7) , 1331-1335
The Pronucleotide Approach. III. Synthesis, Anti-HBV Activity and Stability Studies of the Bis(S-pivaloyl-2-thioethyl) Phosphotriester Derivative of Acyclovir
The nucleoside analog Acyclovir (ACV) is used in the treatment of herpes simplex (HSV) and varicella-zoster (VZV) diseases. The possibility to extend the application field of ACV by using the bis[SATE] pronucleotide approach in order to deliver ACVMP inside the cell was investigated. And actually, the title compound has potent anti-hepatitis B activity in cell culture experiments. Here, we also report its synthesis and stability in various media.
- 1 July 1997
- Published by Taylor & Francis in Nucleosides and Nucleotides
- Vol. 16 (7) , 1331-1335
The Pronucleotide Approach. III. Synthesis, Anti-HBV Activity and Stability Studies of the Bis(S-pivaloyl-2-thioethyl) Phosphotriester Derivative of Acyclovir
The nucleoside analog Acyclovir (ACV) is used in the treatment of herpes simplex (HSV) and varicella-zoster (VZV) diseases. The possibility to extend the application field of ACV by using the bis[SATE] pronucleotide approach in order to deliver ACVMP inside the cell was investigated. And actually, the title compound has potent anti-hepatitis B activity in cell culture experiments. Here, we also report its synthesis and stability in various media.
- 1 January 1994
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 1
- No. 8,p. 1019-1024
Nucleoside analogues. Synthesis of 2′,3′-dideoxy and 2′,3′-unsaturated ribofuranonucleosides of 5,6-dichloro-2-mercaptobenzimidazole as potential antiviral agents
Novel benzimidazole nucleoside derivatives structurally related to 5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (DRB) and to tetrahydroimidazobenzodiazepinethione (TIBO) compounds have been synthesized and their antiviral properties examined. The 2′,3′-unsaturated nucleoside was obtained following chemical transformations of the corresponding β-D-ribofuranonucleoside, whereas the 2′,3′-dideoxynucleoside was synthesized by a glycosylation reaction between a suitably protected 2,3-dideoxy-D-glycero-pentofuranose and silylated 5,6-dichloro-2-mercaptobenzimidazole. The prepared compounds were tested for their activity against HIV and against a variety of RNA and DNA viruses, but they did not show significant antiviral activity.
- 1 January 1994
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 1
- No. 8,p. 1019-1024
Nucleoside analogues. Synthesis of 2′,3′-dideoxy and 2′,3′-unsaturated ribofuranonucleosides of 5,6-dichloro-2-mercaptobenzimidazole as potential antiviral agents
Novel benzimidazole nucleoside derivatives structurally related to 5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (DRB) and to tetrahydroimidazobenzodiazepinethione (TIBO) compounds have been synthesized and their antiviral properties examined. The 2′,3′-unsaturated nucleoside was obtained following chemical transformations of the corresponding β-D-ribofuranonucleoside, whereas the 2′,3′-dideoxynucleoside was synthesized by a glycosylation reaction between a suitably protected 2,3-dideoxy-D-glycero-pentofuranose and silylated 5,6-dichloro-2-mercaptobenzimidazole. The prepared compounds were tested for their activity against HIV and against a variety of RNA and DNA viruses, but they did not show significant antiviral activity.